Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: Exploratory results via literature-based modeling

Current Medical Research and Opinion

Volumn 24, Issue 3, 2008, Pages 753-768

  Ballal, Rahul D ^a   Botteman, Marc F ^b   Foley, Isaac ^b   Stephens, Jennifer M ^b   Wilke, Caitlyn T ^c,d   Joshi, Ashish V ^c  

^a GEORGETOWN UNIVERSITY   (United States)

^b PHARMERIT INTERNATIONAL   (United States)

^c NOVO NORDISK INC   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cost effectiveness; Hemophilia; Inhibitors; Orthopedic surgery; rFVIIa

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADVANCED KNEE ARTHROPATHY; ANALGESIA; ARTHRODESIS; ARTHROPATHY; ARTICLE; BLEEDING; COHORT ANALYSIS; COST CONTROL; COST OF ILLNESS; DRUG COST; ECONOMIC EVALUATION; ELECTIVE SURGERY; EXPLORATORY RESEARCH; FEMUR OSTEOTOMY; HEMOPHILIA; HUMAN; KNEE SURGERY; MAJOR CLINICAL STUDY; MAJOR SURGERY; PERIOPERATIVE PERIOD; QUALITY OF LIFE; TIBIA OSTEOTOMY; TOTAL KNEE REPLACEMENT;

ADULT; ARTHROPLASTY, REPLACEMENT, KNEE; COST-BENEFIT ANALYSIS; DECISION TREES; DISEASE PROGRESSION; FACTOR VIIA; FEMALE; HEMOPHILIA A; HUMANS; LIFE TABLES; MALE; MODELS, ECONOMIC; POSTOPERATIVE HEMORRHAGE; QUALITY OF LIFE; RECOMBINANT PROTEINS; SURGICAL PROCEDURES, ELECTIVE;

EID: 41149085573     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079908X273048     Document Type: Article

References (78)

1. Shapiro AD, Gilchrist GS, Hoots WK, et al. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 1998;80:773-8
2. Gamble JG, Bellah J, Rinsky LA, Glader B. Arthropathy of the ankle in hemophilia. J Bone Joint Surg Br 1991;73-A:1008-15
3. Smith MA, Savidge GF, Fountain EJ. Interposition arthroplasty in the management of advanced haemophilic arthropathy of the elbow. J Bone Joint Surg Br 1983;65:436-40
4. Wallny T, Brackmann HH, Hess L, et al. Long-term follow-up after intertrochanteric varus osteotomy for haemophilic arthropathy of the hip. Haemophilia 2002;8:149-52
5. Ingerslev J. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors. Semin Thromb Hemost 2000;26:425-32
6. Rodriguez-Merchan EC, Rocino A, Ewenstein B, et al. Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement. Haemophilia 2004;10(Suppl 2):50-22
7. Cooper HA, Jones CP, Campion E, et al. Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures. Haemophilia 2001;7:517-22
8. Abshire T, Kenet G. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors. J Thromb Haemost 2004;2:899-909
9. Kulkarni R, Aledort L, Berntorp E, et al. Therapeutic choices for patients with hemophilia and high-titer inhibitors. Am J Hematol 2001;67:240-6
10. Leissinger CA. Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction. Am J Hematol 2004;77:187-93.
11. Hvid I, Rodriguez-Merchan EC. Orthopaedic surgery in haemophilic patients with inhibitors: an overview. Haemophilia 2002;8:288-91
12. Faradji A, Bonnomet F, Lecocq J, et al. Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven): a new case report and review of the literature. Haemophilia 2001;7:321-6
13. Rodriguez-Merchan EC, Wiedel JD, Wallny T, et al Elective orthopaedic surgery for inhibitor patients. Haemophilia 2003;9:625-31
14. Rodriguez-Merchan EC, Wiedel JJ, Wallny T, et al. Elective orthopedic surgery for hemophilia patients with inhibitors: New opportunities. Semin Hematol 2004;41(1 Suppl 1):109-16
15. Augereau B, Travers V, Le Balch T, Witvoet J. Les arthroplasties totales de hanche et de genou chez l'hemophile. Rev Chir Orthop 1987;73:381-94
16. Cohen I, Heim M, Martinowitz U, Chechick A. Orthopaedic outcome of total knee replacement in haemophilia A. Haemophilia 2000;6:104-9
17. Goldberg VM, Heiple KG, Ratnoff OD, et al. Total knee arthroscopy in classic hemophilia. J Bone Joint Surg Br 1981;63-A:695-701
18. Heeg M, Meyer K, Smid WM, et al. Total knee and hip arthroplasty in haemophilic patients. Haemophilia 1998;4:747-51
19. Kjaersgaard-Andersen P, Christiansen SE, Ingerslev J, et al. Total knee arthroplasty in classic hemophilia. Clin Orthop Relat Res 1990;256:137-46
20. Legroux-Gerot I, Strouk G, Parquet A, et al. Total knee arthroplasty in hemophilic arthropathy. Joint Bone Spine 2003;70:22-32
21. Nelson IW, Sivamurugan S, Latham PD, et al. Total hip arthroplasty for hemophilic arthropathy. Clin Orthop Relat Res 1992;276:210-13
22. Rodriguez-Merchan EC, Wiedel JD. Total knee arthroplasty in HIV-positive haemophilic patients. Haemophilia 2002;8:387-92
23. Schick M, Stucki G, Rodriguez M, Meili EO, et al. Haemophilic; arthropathy: assessment of quality of life after total knee arthroplasty. Clin Rheumatol 1999;18:468-72
24. Sheth DS, Oldfield D, Ambrose C, Clyburn T. Total knee arthroplasty in hemophilic arthropathy. J Arthroplasty 2004;19:56-60
25. Smith MA, Urquhart DR, Savidge GF. The surgical management of varus deformity in haemophilic arthropathy of the knee. J Bone Joint Surg Br 1981;63-B:261-5
26. Thomason HC, III, Wilson FC, Lachiewicz PF, Kelley SS. Knee arthroplasty in hemophilic arthropathy. Clin Orthop Relat Res 1999;360:169-73
27. Wallny T, Saker A, Hofmann P, et al. Long-term follow-up after osteotomy for haemophilic arthropathy of the knee. Haemophilia 2003;9:69-75
28. Healthcare Cost and Utilization Project (HCUP) Database, http://www.ahrq.gov/data/hcup. 2005 Ref Type: Electronic Citation
29. How much does a hospital day cost? 11th Annual International Society for Pharmacoeconomics and Outcomes Research, 2006
30. Silva M, Luck JV, Jr. Long-term results of primary total knee replacement in patients with hemophilia. J Bone Joint Surg Am 2005;87:85-91
31. Norian JM, Ries MD, Karp S, Hambleton J. Total knee arthroplasty in hemophilic arthropathy. J Bone Joint Surg Am 2002;84-A:1138-41
32. Hicks JL, Ribbans WJ, Buzzard B, et al. Infected joint replacements in HIV-positive patients with haemophilia. J Bone Joint Surg Br 2001;83:1050-4
33. Beeton K. A review of TKRs. World Federation of Haemophilia Conference, 2000
34. Green C, De Cock E. Cost-consequences of orthopaedic surgery in haemophilia patients with inhibitors. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 4th Annual European Congress, Cannes, France, November 11-13, 2001
35. Knight C, Paisley S, Wight J, Jones ML. Economic modelling of different treatment strategies for haemophilia A with high-responding inhibitors. Haemophilia 2003;9:521-40
36. Joshi AV, Stephens JM, Munro V, et al. Pharmacoeconomic analysis of recombinant factor VIIa versus APCC in the treatment of minor-to-moderate bleeds in hemophilia patients with inhibitors. Curr Med Res Opin 2006;22:23-31
37. Aznar JA, Magallón M, Querol F, et al. The orthopaedic status of severe haemophiliacs in Spain. Haemophilia 2000;6:170-6
38. Molho P, Rolland N, Lebrun T, et al. Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group, secretariat.haemophiles@cch.ap-hop-paris.fr. Haemophilia 2000;6:23-32
39. Solovieva S. Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders. Haemophilia 2001;7:53-63
40. Scalone L, Mantovani LG, Mannucci PM, Gringeri A. Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia 2006;12:154-62
41. Barr RD, Saleh M, Furlong W, et al. Health status and health-related quality of life associated with hemophilia. Am J Hematol 2002;71:152-60
42. Arranz P, Remor E, Quintana M, et al. Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia. Haemophilia 2004;10:376-82
43. Atilla B. Total knee arthroplasty in hemophilic arthropathy. J Arthroplasty 2005;20:131
44. Beeton K. Evaluation of outcome of care in patients with haemophilia. Haemophilia 2002;8:428-34
45. Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000;17:13-35
46. De KP, Heijnen L, Van Meeteren NL. Clinimetric instruments to assess functional health status in patients with haemophilia: a literature review. Haemophilia 2002;8:419-27
47. Figgie MP, Goldberg VM, Figgie HE, III, et al. Total knee arthroplasty for the treatment of chronic hemophilic arthropathy. Clin Orthop Relat Res 1989;248:98-107
48. Fischer K, Bom JG, Mauser-Bunschoten EP, et al. Effects of haemophilic arthropathy on health-related quality of life and socio-economic parameters. Haemophilia 2005;11:43-8
49. Fischer K, van der Bom JG, van den Berg HM. Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia 2003;9(Suppl 1):75-81
50. Gringeri A, Mantovani LG, Scalone L, Mannucci PM. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003;102:2358-63
51. Hirvonen J, Blom M, Tuominen U, et al. Health-related quality of life in patients waiting for major joint replacement. A comparison between patients and population controls. Health Qual Life Outcomes 2006;4:3
52. Karthaus RP, Novakova IRO. TKR in haemophilic arthropathy. J Bone Joint Surg Br 1988;70-B:382-5
53. Knight C. Health economics of treating haemophilia A with inhibitors. Haemophilia 2005;11(Suppl 1):11-17
54. Lachiewicz PF, Inglis AE, Insall JN. Total knee arthroscopy in hemophilia. J Bone Joint Surg 1985;9:1361-6
55. Lingard EA, Katz JN, Wright RJ, et al. Validity and responsiveness of the Knee Society Clinical Rating System in comparison with the SF-36 and WOMAC. J Bone Joint Surg Am 2001;83-A:1856-64
56. Miners AH, Sabin CA, Tolley KH, Jenkinson C, et al. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999;5:378-85
57. Pearce MS, Smith MA, Savidge GF. Supramalleolar tibial osteotomy for haemophilic arthropathy of the ankle. J Bone Joint Surg Br 1994;76:947-50
58. Szende A, Schramm W, Flood E, et al. Health-related quality of life assessment in adult haemophilia patients: a systematic review and evaluation of instruments. Haemophilia 2003;9:678-87
59. Wolfe F. Determinants of WOMAC function, pain and stiffness scores: evidence for the role of low back pain, symptom counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia. Rheumatology (Oxford) 1999;38:355-61
60. Mehta S, Nelson CL, Konkle BA, Vannozzi B. Total knee arthroplasty in hemophilia-A patients with inhibitors. J Bone Joint Surg Br 2004;86-A:2519-921
61. Rothwell AG, Faed JM. The performance of multiple joint procedures at one operation in a patient with haemophilia. Aust N Z J Surg 1979;49:476-9
62. Agency for Healthcare Research and Quality. Calculation the US Population-based EQ-5D Index Score, http://www.ahrq.gov/rice/EQ5Dscore.htm . 2005. Ref Type: Electronic Citation
63. Plug I, van der Bom JG, Peters M, et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006;4:510-16
64. Arias E. United States Life Tables, 2003. v54 n14. 2006. National Center for Health Statistics. Ref Type: Report
65. Birch NC, Ribbans WJ, Goldman E, Lee CA. Knee replacement in haemophilia. J Bone Joint Surg Br 1994;76:165-6
66. McCollough NC, III, Enis JE, Lovitt J, et al. Synovectomy or total replacement of the knee in hemophilia. J Bone Joint Surg Am 1979;61:69-75
67. Marmor L. Total knee replacement in hemophilia. Clin Orthop Relat Res 1977;125:192-5
68. Small M, Steven MM, Freeman PA, et al. Total knee arthroplasty in haemophilic arthritis. J Bone Joint Surg Br 1983;65:163-5
69. Teigland JC, Tjonnfjord GE, Evensen SA, Charania B. Knee arthroplasty in hemophilia. 5-12 year follow-up of 15 patients. Acta Orthop Scand 1993;64:153-6
70. Trieb K, Panotopoulos J, Hard H, et al. Outcome of osteotomies for the treatment of haemophilic arthropathy of the knee. Langenbecks Arch Surg 2004;389:209-12
71. Vastel L, Courpied JP, Sultan Y, Kerboull M. [Knee replacement arthroplasty in hemophilia: results, complications and predictive elements of their occurrence]. Rev Chir Orthop Reparatrice Appar Mot 1999;85:458-65
72. Carr ME, Jr, Loughran TP, Cardea JA, et al. Successful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor. Int J Hematol 2002;75:95-9
73. Goddard N. Case studies: orthopaedic surgery in adult patients with haemophilia A with inhibitors. Haemophilia 2005;11(Suppl 1):32-7
74. US Physical Therapy National Operator of 250 nationwide outpatient clinics Second Quarter Financial Results, http://www.usph.com/Uploads/Press/ Q2%202006%20Earnings%20Release%20Final.pdf. 2006. Ref Type: Electr onic Citation
75. Kramer JF, Speechley M, Bourne R, et al. Comparison of clinic- and home-based rehabilitation programs after total knee arthroplasty. Clin Orthop Relat Res 2003;410:225-34
76. Oldmeadow LB, McBurney H, Robertson VJ. Hospital stay and discharge outcomes after knee arthroplasty: implications for physiotherapy practice. Aust J Physiother 2002;48:117-21
77. State of Minnesota Total Physiotherapy Rehabilitation Cost, Comparative Pricing Information for Inpatient Hospital Care. http://www.centracare.com/sch/ quality/pricing_info.html. 2007. Ref Type: Electronic Citation
78. Medicare Home Health Care Report, GAO 02-663, Analysis of CMS claims January-June 2001. http://www.gao.gov/new.items/d02663.pdf. 2002. Ref Type: Electronic Citation